Research Articles | Page 15 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Germline DDX41 mutations define a significant entity within adult MDS/AML patients Sep 2019 Blood Myelodysplastic Syndromes (MDS)
Germline mutations in MDS/AML predisposition disorders Mar 2021 Current opinion in hematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT Oct 2023 Lancet Hematology Myelodysplastic Syndromes (MDS)
Germline variants in acquired aplastic anemia: current knowledge and future perspectives Sep 2024 Haematologica Aplastic Anemia
Getting personal with myelodysplastic syndromes: is now the right time? Apr 2019 Expert Review of Hematology Myelodysplastic Syndromes (MDS)
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Jul 2020 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes Aug 2020 Cancer Myelodysplastic Syndromes (MDS)
Granulocyte transfusions in severe aplastic anemia Jun 2024 Haematologica Aplastic Anemia
Granulocyte transfusions in severe aplastic anemia Dec 2023 Haematologica Aplastic Anemia
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial Jun 2019 The Lancet Haematology Myelodysplastic Syndromes (MDS)